Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage von Yamamoto, Yuji, Matsui, Junji, Matsushima, Tomohiro, Obaishi, Hiroshi, Miyazaki, Kazuki, Nakamura, Katsuji, Tohyama, Osamu, Semba, Taro, Yamaguchi, Atsumi, Hoshi, Sachi Suzuki, Mimura, Fusayo, Haneda, Toru, Fukuda, Yoshio, Kamata, Jun-Ichi, Takahashi, Keiko, Matsukura, Masayuki, Wakabayashi, Toshiaki, Asada, Makoto, Nomoto, Ken-Ichi, Watanabe, Tatsuo, Dezso, Zoltan, Yoshimatsu, Kentaro, Funahashi, Yasuhiro, Tsuruoka, Akihiko

Volltext